Applications of an athymic nude mouse model of nonhealing critical-sized calvarial defects

Deepak M Gupta1, Matthew D Kwan, Bethany J Slater

  • 1Hagey Laboratory for Pediatric Regenerative Medicine, Department of Plastic and Reconstructive Surgery, Stanford University School of Medicine, 257 Campus Drive, Stanford, CA 94305, USA.

Insights

This study established a critical-sized calvarial defect model in nude mice to investigate human osteoprogenitor cells for bone regeneration. The model showed no spontaneous healing, highlighting its utility for future cell-based therapy research.

Area of Science:

  • Regenerative Medicine
  • Craniofacial Surgery
  • Bone Biology

Background:

  • Calvarial bone defects present significant challenges in craniofacial surgery.
  • Current reconstruction methods have limitations, necessitating novel approaches.
  • Cell-based therapies offer a promising avenue for bone defect repair.

Purpose of the Study:

  • To establish and validate a critical-sized calvarial defect model in nude mice.
  • To assess the in vivo behavior of human osteoprogenitor cells in this model.
  • To provide a controlled environment for future translational research in craniofacial bone regeneration.

Main Methods:

  • Created critical-sized 4.0-mm calvarial defects in nude mice (n=15).
  • Utilized a custom trephine drill bit, preserving the dura mater.
  • Evaluated defect healing via gross inspection, histology, and micro-computed tomography at 2, 4, 8, and 16 weeks.

Main Results:

  • No spontaneous calvarial bone healing was observed in any animal by 16 weeks.
  • The dura mater remained intact throughout the study period.
  • Histological and radiographic analyses confirmed the lack of defect closure.

Conclusions:

  • The nude mouse critical-sized calvarial defect model is a reliable platform for studying bone regeneration.
  • This model provides a suitable control for investigating human osteoprogenitor cell efficacy.
  • Further research using this model can advance the clinical translation of regenerative medicine for craniofacial defects.

Related Concept Videos